Adial Pharmaceuticals, Inc. (ADIL)

CIK 1513525 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adial Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 2026S-30001213900-26-095122
Aug 28, 2026S-80001213900-26-095119
Aug 25, 20268-K0001213900-26-093544
Aug 24, 2026DEF 14A0001213900-26-093019
Aug 24, 2026ARS0001213900-26-093022
Aug 21, 20268-K0001213900-26-092690
Aug 17, 20268-K0001213900-26-090482
Aug 14, 202610-Q0001213900-26-090051
Aug 13, 20268-K0001213900-26-089270
Aug 11, 2026PRE 14A0001213900-26-087445
Aug 11, 20268-K/A0001213900-26-087439
Jul 16, 202640001104659-26-084300
Jul 13, 202640001104659-26-082972
Jul 1, 202640001104659-26-079686
Jul 1, 2026SCHEDULE 13G/A0001104659-26-079983
Jun 29, 202630001104659-26-078710
Jun 24, 2026SCHEDULE 13G0001104659-26-077127
Jun 16, 202640001213900-26-069037
Jun 16, 202630001213900-26-069015
Jun 16, 202630001213900-26-069035
Jun 16, 202640001213900-26-069021
Jun 11, 20268-K0001213900-26-067711
May 15, 2026SCHEDULE 13G/A0001172661-26-002114
May 11, 20268-K0001213900-26-054219
May 8, 202610-Q0001213900-26-053907